Guarana (Paullinia cupana Mart.) prevents β-amyloid aggregation, generation of advanced glycation-end products (AGEs), and acrolein-inducedcytotoxicity onhuman neuronal-likecells

Phytotherapy Research

Volumn 28, Issue 11, 2014, Pages 1615-1624

  Da Silva Bittencourt, Leonardo ^a   Zeidán Chuliá, Fares ^a   Yatsu, Francini Kiyono Jorge ^a   Schnorr, Carlos Eduardo ^a   Moresco, Karla Suzana ^a   Kolling, Eduardo Antônio ^a   Gelain, Daniel Pens ^a   Bassani, Valquiria Linck ^a   Moreira, José Cláudio Fonseca ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Alzheimer's disease; Caffeine; Natural products; Neurodegenerative diseases; Neuroprotection; Polyphenols

Indexed keywords

ACROLEIN; ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN; GLYOXAL; GUARANA EXTRACT; METHYLGLYOXAL; REACTIVE OXYGEN METABOLITE; AMYLOID BETA-PROTEIN (1-42); ANTIOXIDANT; PEPTIDE FRAGMENT; PLANT EXTRACT;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; PHYTOCHEMISTRY; PROTEIN AGGREGATION; PROTEIN GLYCOSYLATION; BRAZIL; CHEMISTRY; DRUG EFFECTS; METABOLISM; NERVE CELL; NEUROBLASTOMA; PAULLINIA; PROTEIN AGGREGATION, PATHOLOGICAL; TUMOR CELL LINE;

PAULLINIA CUPANA;

ACROLEIN; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; BRAZIL; CELL LINE, TUMOR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NEUROBLASTOMA; NEURONS; PAULLINIA; PEPTIDE FRAGMENTS; PLANT EXTRACTS; PROTEIN AGGREGATION, PATHOLOGICAL; REACTIVE OXYGEN SPECIES;

EID: 84914708068     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5173     Document Type: Article

References (63)

1. Albarracin SL, Stab B, Casas Z, et al. 2012. Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci 15: 1-9.
2. Ângelo PC, Nunes-Silva CG, Brigido MM, et al. 2008. Guarana (Paullinia cupana var. Sorbilis), an ancient consumed stimulant from the Amazon rainforest: the seeded-fruit transcriptome. Plant Cell Rep 27: 117-124.
3. Arendash GW, Cao C. 2010. Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimers Dis 20(Suppl 1): S117-S126.
4. Basile A, Ferrara L, Pezzo MD, et al. 2005. Antibacterial and antioxidant activities of etanol extract from Paullinia cupana Mart. J Ethnopharmacol 102: 32-36.
5. Bittencourt LS, Machado DC, Machado MM, et al. 2013. The protective effects of guaraná extract (Paullinia cupana) on fibroblast NIH-3 T3 cells exposed to sodium nitroprusside. Food Chem Toxicol 53: 119-125.
6. Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. 2001. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord 25: 316-324.
7. Byun K, Bayarsaikhan E, Kim D, et al. 2012. Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease. PLoS One 7: e37917. doi:10.1371/journal. pone.0037917
8. Bradley MA, Markesbery WR, Lovell MA. 2010. Increased levels of 4-hydroxynonenal and Acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 48: 1570-1576.
9. Carlson M, Thompson RD. 1998. Liquid chromatographic determination of methylxanthines and catechins in herbal preparations containing guaraná. J AOAC Int 81: 691-701.
10. Chen Z, Zhong C. 2013. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies. Prog Neurobiol 108: 21-43.
11. Cheung YT, Lau WK, Yu MS, et al. 2009. Effects of all trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30: 127-135.
12. da Frota Junior ML, Pires AS, Zeidán-Chuliá F, et al. 2011. In vitro optimization of retinoic acid-induced neuritogenesis and TH endogenous expression in human SH-SY5Y neuroblastoma cells by the antioxidant Trolox. Mol Cell Biochem 358: 325-334.
13. Dalonso N, Petkowicz CL. 2012. Guarana powder polysaccharides: characterization and evaluation of the antioxidant activity of a pectic fraction. Food Chem 134: 1804-1812.
14. Dang TN, Arseneault M, Murthy V, Ramassamy C. 2010a. Potential role of Acrolein in neurodegeneration and in Alzheimer's disease. Curr Mol Pharm 3: 66-78.
15. Dang TN, Arseneault M, Zarkovic N, Waeg G, Ramassamy C. 2010b. Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease. J Alzheimers Dis 21: 1197-1216.
16. Dang TN, Arseneault M, Ramassamy C. 2011. Regulation of redox-sensitive signaling pathways in rat primary astrocytes following Acrolein exposure. J Alzheimers Dis 25: 263-277.
17. Dearlove RP, Greenspan P, Hartle DK, Swanson RB, Hargrove JL. 2008. Inhibition of protein glycation by extracts of culinary herbs and spices. J Med Food 11: 275-281.
18. Dresch MTK, Rossato SB, Kappel VD, et al. 2009. Optimization and validation of an alternative method to evaluate total reactive antioxidant potential. Anal Biochem 385: 107-14.
19. Edison P, Archer HA, Gerhard A, et al. 2008. Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32: 412-419.
20. Ferreira N, Saraiva MJ, Almeida MR. 2012. Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy. Amyloid 19(Suppl 1): 39-42.
21. Fukumasu H, Avanzo JL, Heidor R, et al. 2006. Protective effects of guarana (Paullinia cupana Mart. Var. Sorbilis) against DEN-induced DNA damage on mouse liver. Food Chem Toxicol 44: 862-867.
22. Fukumasu H, Latorre AO, Zaidan-Dagli ML. 2011. Paullinia cupana Mart. Var. sorbilis, guarana, increase survival of Ehrlich ascites carcinoma (EAC) bearing mice by decreasing cyclin-D1 expression and inducing a G0/G1 cell cycle arrest in EAC cells. Phytother Res 25: 11-16.
23. Galimberti D, Scarpini E. 2012. Progress in Alzheimer's disease. J Neurol 259: 201-211.
24. Haskell CF, Kennedy DO, Wesnes KA, Milne AL, Scholey AB. 2007. A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans. Psychopharmacol 21: 65-70.
25. Hickman SE, Allison EK, El Khoury J. 2008. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28: 8354-8360.
26. Krautwald M, Leech D, Horne S, et al. 2011. The advanced glycation end product-lowering agent ALT-711 is a lowaffinity inhibitor of thiamine diphosphokinase. Rejuvenation Res 14: 383-391.
27. Kuhla B, Haase C, Flach K, Luth HJ, Arendt T, Munch G. 2007. Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem 282: 6984-6991.
28. LaFerla FM, Oddo S. 2005. Alzheimer's disease: A?, tau, and synaptic dysfunction. Trends Mol Med 11: 170-176.
29. Loewen CA, Feany MB. 2010. The unfolded protein response protects from tau neurotoxicity in vivo. PLoS One 5(9). pii: e13084. doi:10.1371/journal.pone.0013084
30. Matter R, Dias RF, Espinola EB, Carlini EA, Barros SB. 1998. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidant activity in vitro. J Ethnopharmacol 60: 111-116.
31. Navarra M, Celano M, Maiuolo J, et al. 2010. Antiproliferative and pro-apoptotic effects afforded by novel Src kinase inhibitors in human neuroblastoma cells. BMC Cancer 10: 602-614.
32. Nicolini G, Miloso M, Zoia C, Di Silvestro A, Cavaletti G, Tredici G. 1998. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to asses drug neurotoxicity. Anticancer Res 18: 2477-2481.
33. Nijmeh J, Moldobaeva A, Wagner EM. 2010. Role of ROS in ischemia-induced lung angiogenesis. Am J Physiol Lung Cell Mol Physiol 299: L535-L541.
34. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T. 1984. Retinoic acid induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14: 135-144.
35. Prasanthi JR, Dasari B, Marwarha G, et al. 2010. Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med 49: 1212-1220.
36. Praticò D. 2008. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 29: 609-615.
37. Querfurth HW, LaFerla FM. 2010. Alzheimer's disease. N Engl J Med 362: 329-344.
38. Rabelo TK, Zeidán-Chuliá F, Vasques LM, et al. 2012. Redox characterization of usnic acid and its cytotoxic effect on human neuron-like cells (SH-SY5Y). Toxicol In Vitro 26: 304-314.
39. Ravi Subbiah MT, Yunker R. 2008. Studies on the nature of antiplatelet aggregatory factors in the seeds of the Amazonian Herb Guaraná (Paullinia cupana). Int J Vitam and Nutr Res 78: 96-101.
40. Seidler NW, Squire TJ. 2005. Abeta-polyacrolein aggregates: novel mechanism of plastic formation in senile plaques. Biochem Biophys Res Commun 335: 501-504.
41. Singh M, Dang TN, Arseneault M, Ramassamy C. 2010. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on Acrolein. J Alzheimers Dis 21: 741-756.
42. Sousa SA, Alves SF, De Paula JAM, Fiuza TS, Paula JR, Bara MTF. 2010. Determination of tannins andmethylxanthines in powdered guarana (Paullinia cupana Kunth, Sapindaceae) by high performance liquid chromatography. Braz J Pharmacogn 20: 866-870.
43. Sousa SA, Pascoa H, Conceição EC, et al. 2011. Dissolution test of herbal medicines containing Paullinia cupana: validation of methods for quantification and assessment of dissolution. Braz J Pharm Sci 47: 269-277.
44. Srivastava S, Sithu SD, Vladykovskaya E, et al. 2011. Oral exposure to Acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 215: 301-308.
45. Subbiah MT, Yunker R. 2008. Studies on the nature of anti-platelet aggregatory factors in the seeds of the Amazonian Herb Guarana (Paullinia cupana). Int J Vitam Nutr Res 78: 96-101.
46. Toda T, Sunagawa T, Kanda T, Tagashira M, Shirasawa T, Shimizu T. 2011. Apple Procyanidins Suppress Amyloid ?-Protein Aggregation. Biochem Res Int 2011: 784698.
47. Tomitori H, Nakamura M, Sakamoto A, et al. 2012. Augmented glutathione synthesis decreases acrolein toxicity. Biochem Biophys Res Commun 418: 110-115.
48. Vinson JA, Howard TB. 1996. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 7: 659-663.
49. Vichai V, Kirtikara K. 2006. Sulforhodamine B colorimetric assay for cytoxicity screening. Nat Protoc 1: 1112-1116.
50. Wang SW, Wang YJ, Su YJ, et al. 2012. Rutin inhibits ?-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology 33: 482-490.
51. Woods DJ. 2012. Guarana: Paullinia cupana, P. sorbilis; also known as Brazilian cocoa and 'zoom'. J Prim Health Care 4: 163-164.
52. Yan SD, Chen X, Fu J, et al. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
53. Yankner BA. 1996. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932.
54. Yu J, Ye J, Liu X, Han Y, Wang C. 2011. Protective effect of L-carnintine against H(2)O(2)-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells. Neurol Res 33: 708-716.
55. Zanotto-Filho A, Braganhol E, Edelweiss MI, et al. 2012. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J Nutr Biochem 23: 591-601.
56. Zeidán-Chuliá F, Gelain DP, Kolling EA, et al. 2013a. Major Components of Energy Drinks (Caffeine, Taurine, and Guarana) Exert Cytotoxic Effects on Human Neuronal SH-SY5Y Cells by Decreasing Reactive Oxygen Species Production. Oxid Med Cell Longev 2013: 791795.
57. Zeidán-Chuliá F, Neves de Oliveira BH, Gursoy M, et al. 2013b. MMP-REDOX/NO interplay in periodontitis and its inhibition with Satureja hortensis L. essential oil. Chem Biodivers 10: 507-523.
58. Zeidán-Chuliá F, Rybarczyk-Filho JL, Gursoy M, et al. 2012. Bioinformatical and in vitro approaches to essential oilinduced matrix metalloproteinase inhibition. Pharm Biol 50: 675-686.
59. Zeidán-Chuliá F, Gursoy M, de Oliveira BH, et al. 2014a. Focussed microarray analysis of apoptosis in periodontitis and its potential pharmacological targeting by carvacrol. Arch Oral Biol 59: 461-469.
60. Zeidán-Chuliá F, Keskin M, Könönen E, et al. 2014b. Antibacterial and Antigelatinolytic Effects of Satureja hortensis L. Essential Oil on Epithelial Cells Exposed to Fusobacterium nucleatum. J Med Food. doi: 10.1089/jmf.2013.0052
61. Zhao Y, Zhao B. 2012. Natural antioxidants in prevention andmanagement of Alzheimer's disease. Front Biosci (Elite Ed) 4: 794-808.
62. Zhu Q, Sun Z, Jiang Y, Chen F,WangM. 2011. Acrolein scavengers: reactivity, mechanism and impact on health. Mol Nutr Food Res 55: 1375-1390.
63. Zhu Q, Zheng ZP, Cheng KW, et al. 2009. Natural Polyphenols as direct trapping agents of lipid peroxidation derived-acrolein and 4-hydroxy-trans-2-nonenal. Chem Res Toxicol 22: 1721-1727.